Palisade Bio (PALI) Retained Earnings (2010 - 2026)

Palisade Bio (PALI) has 17 years of Retained Earnings data on file, last reported at $288.0 million in Q1 2026.

• On a quarterly basis, Retained Earnings rose 308.44% year-over-year to $288.0 million in Q1 2026; TTM through Mar 2026 was $288.0 million, a 308.44% increase from a year earlier, with the FY2025 full-year figure at $280.5 million, up 95.6% from the prior year.
• Retained Earnings for Q1 2026 stood at $288.0 million, up from $280.5 million in the prior quarter.
• Over the last five years, Retained Earnings for PALI reached as high as $288.0 million in Q1 2026 and fell as low as -$143.8 million in Q3 2025.
• Historically, Retained Earnings has averaged $26.5 million across 5 years, with a median of $105.2 million in 2022.
• Across the five-year window, Retained Earnings tumbled 3560670.89% in 2022 and surged 308.44% in 2026, its largest moves.
• Year by year, Retained Earnings stood at -$109.2 million in 2022, then declined by 11.28% to -$121.5 million in 2023, then jumped by 218.02% to $143.4 million in 2024, then surged by 95.6% to $280.5 million in 2025, then increased by 2.67% to $288.0 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $288.0 million in Q1 2026, $280.5 million in Q4 2025, and -$143.8 million in Q3 2025.